Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
25
Number of overlapping holdings
21.2%
% of XBI's 119 holdings also in IDNA
54.3%
% of IDNA's 51 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
REGENERON PHARMACEUTICALS | 2.3% | 3.9% | 2.3% |
|
INCYTE CORP | 2.2% | 3.8% | 2.2% |
|
MODERNA, INC. | 2.2% | 3.3% | 2.2% |
|
EXELIXIS INC | 1.9% | 4.9% | 1.9% |
|
REVOLUTION MEDICINES, INC. | 1.4% | 3.7% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to IDNA
|
ALNYLAM PHARMACEUTICALS INC | 2.8% |
|
INSMED INC | 2.6% |
|
NEUROCRINE BIOSCIENCES INC | 2.6% |
|
UNITED THERAPEUTICS CORP | 2.5% |
|
NATERA INC | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.5% |
|
BIOGEN IDEC INC | 2.5% |
|
AMGEN INC | 2.4% |
|
GILEAD SCIENCES INC | 2.4% |
|
ABBVIE INC | 2.4% |
XBI Underweight Relative to IDNA
 |
BEIGENE, LTD. | -6.2% |
 |
ROCHE HOLDING LTD | -5.5% |
 |
SANOFI-AVENTIS | -5.4% |
 |
GSK PLC | -5.3% |
|
ASTRAZENECA PLC | -5.1% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -4.9% |
 |
GENMAB A/S | -4.3% |
|
MERCK & CO. INC. | -4.1% |
|
SPRINGWORKS THERAPEUTICS, INC. | -3.7% |
 |
BIONTECH SE SPONSORED ADR | -3.7% |